首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1620385

先進藥物輸送的全球市場規模：按產品、按應用、按地區、範圍和預測

Global Advanced Drug Delivery Market Size By Product (Polymeric Drug Delivery, Implants & IUD's), By Application (Hospitals, Diagnostic Centers), By Geographic Scope And Forecast

出版日期: 2024年08月05日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

先進藥物傳輸市場規模及預測

2024年先進藥物輸送市場規模為774.9億美元，預計2024年至2031年複合年增長率為18.60%，2031年達到3033.2億美元。先進的藥物遞送調節藥物釋放速率。疾病的類型、藥物和期望的結果都會影響所使用的創新。先進藥物傳遞系統的目標是盡快將治療劑量的藥物輸送到體內的特定部位，並達到並維持藥物的目標濃度。全球先進藥物輸送市場報告提供了對市場的整體評估。它對關鍵細分市場、趨勢、市場推動因素、市場限制、競爭格局以及在市場中發揮關鍵作用的因素進行了全面分析。

定義全球先進藥物傳輸市場

先進的藥物輸送系統是以更受控的方式將藥物分子輸送到所需目標的最佳化方法。正在開發這些方法來提高現有藥物的治療效果。先進藥物遞送系統的進步取決於以預定速率和緩慢、有針對性的方式遞送藥物以實現原位藥物釋放和吸收。

能夠更有選擇性地將藥物遞送到特定部位，更容易、更精確和更少的一般劑量，全身藥物水平的變異性更小，根據部位和作用機制吸收更一致，有毒化合物更少這些都是先進藥物遞送系統的主要優點超過傳統系統。

先進的藥物遞送系統分為標靶藥物傳遞、聚合物藥物傳遞、緩釋藥物遞送、植入物/子宮內避孕器和前藥。標靶藥物遞送是將藥物部分直接遞送至所需的身體部位的過程，以消除傳統藥物遞送的特定毒性作用並減少治療效果所需的藥物量。前藥是沒有藥理活性的分子，它們在體內經由酵素、化學或兩者的混合物轉化為活性母體藥物。

前藥已經從偶然發現並用作治療藥物，轉變為明確設計的藥物。先進的藥物傳遞系統包括口服、腸胃外、肺部、皮下、透皮和奈米結構，例如奈米結構、奈米球、奈米膠囊、奈米顆粒、脂質體、脂質體、樹枝狀聚合物、合成聚合物和基於脂質的載體系統（例如囊泡載體）。

先進藥物輸送的全球市場概況

推動成長的主要因素之一是慢性病在人群中的快速傳播。慢性病被廣泛認為是持續一年以上並需要持續醫療護理、限制日常活動或兩者兼而有之的問題。此外，全球醫療保健支出的大幅增加正在加強先進藥物輸送市場。

醫療費用增加的主要原因是人口成長，特別是人口老化、慢性病增加、醫療服務使用範圍擴大。增加研發活動以產生新的藥物分子。各種先進藥物傳遞途徑的發展推動了科學技術的進步，以增強藥物化合物的藥效學、藥物毒性、免疫原性、生物相容性、藥物動力學特性和功效。

此外，增加用於開發先進藥物輸送系統、新產品和合作夥伴關係的政府資金和貸款預計將在預測期內促進市場成長。藥物召回和藥物失效的大幅增加預計將限制先進藥物輸送市場的成長。方法開發中的某些技術困難、更嚴格的法規、先進產品的高價格、低收入國家的不可用等是限制全球先進藥物輸送市場成長的因素。

醫療保健費用的增加是由於消費者健康意識的提高、政府和企業的努力以及私人公司為滿足欠發達國家和發展中國家的消費者需求而進行的政府投資。因此，所有這些因素都為投資研究和創新流程以及開發先進的藥物輸送解決方案提供了機會，以提高現有藥物以及未來將開發的新分子實體的療效和可靠治療，從而加速市場增長。

Advanced Drug Delivery Market size was valued at USD 77.49 Billion in 2024 and is projected to reach USD 303.32 Billion by 2031, growing at a CAGR of 18.60% from 2024 to 2031. Advanced drug delivery regulates the rate at which drugs are released. The type of disease, drug, and preferred outcome all have an impact on the innovation used. An advanced drug delivery system's goal is to deliver a therapeutic amount of medication to a specific site in the body as quickly as possible to achieve and then preserve the target concentration of the drug. The Global Advanced Drug Delivery Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Advanced Drug Delivery Market Definition

Advanced drug delivery systems are optimized methods for delivering the drug molecule to the desired target in a more controlled way. These methods are being developed to enhance the improved therapeutic ratio of existing drugs. The advancement of advanced drug delivery systems is predicated on the delivery of drugs at a predetermined rate, and also slow and targeted delivery for onsite drug release and absorption.

The ability to deliver a drug more selectively to a particular site, easier, more precise, less common dosing, reduced variability in systemic drug levels, absorption that is more constant with the site and mode of action, and reductions in toxic compounds are all major benefits of advanced drug delivery systems over traditional systems.

The Advanced Drug Delivery System is classified as Targeted Drug Delivery, Polymeric Drug Delivery, Sustained Release, Implants & IUDs, and Prodrugs. Targeted drug delivery is a process of providing a drug moiety directly into its intended body area to resolve the specific toxic effect of conventional drug delivery and thus decrease the amount of drug needed for therapeutic efficacy. Prodrugs are molecules with no pharmacological activity that are transformed to the active parent drug in vivo through enzymatic, chemical, or a mixture of the two.

Prodrugs have advanced from being discovered by possibility and used as a salvage effort to just being designed explicitly. The advanced drug delivery system contains oral, parenteral, pulmonary, subcutaneous, transdermal, and carrier-based systems such as nanostructures, Nanospheres, Nanocapsules, nanoparticles, and Nano-sized vesicular carriers including such liposomes, noisome, dendrimers, and synthetic polymer or lipid-based carriers, and other drug delivery systems.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Advanced Drug Delivery Market Overview

One of the major factors driving the growth is the rapid spread of chronic diseases in the overall population. The chronic disease known broadly as a problem that lasts a year or longer and necessarily require ongoing medical care, confine daily activities, or both. Moreover, the substantial increase in global health expenditures has enhanced the Advanced Drug Delivery Market.

The main causes of the increase in medical expenditure are a rise in population, especially geriatrics, an increase in chronic conditions, and enhanced medical service utilization. Growing R&D activities to bring new drug molecules. By developing different advanced drug delivery routes, science and technological advances have been made to develop advanced drug delivery systems to increase the pharmacodynamics, drug toxicity, immunogenicity, biocompatibility, pharmacokinetic properties, and efficacy of drug compounds.

Furthermore, increased government funding and financing, new products, and collaborative partnerships for the development of advanced drug delivery systems are projected to boost market growth over the forecast period. The substantial rise in the number of drugs recalls and drug failures are expected to restrict the growth of the Advanced Drug Delivery Market. Certain technical difficulties in method development, stricter regulations, high pricing for advanced products, and non-availability in low-income countries are among the factors that limit Global Advanced Drug Delivery Market growth.

The increase in healthcare costs has been attributed to the increased consumer awareness of health, enhanced government and corporate initiatives, and government investment by public-private sector companies to fulfill consumer demands in underdeveloped and developing countries. As an outcome, all of these factors provide opportunities for investments in the Research and innovation process and the development of advanced drug delivery solutions for improved drug efficacy and secure therapy for existing drugs as well as upcoming novel molecular entities, which accelerates the market growth.

Global Advanced Drug Delivery Market Segmentation Analysis

The Global Advanced Drug Delivery Market is segmented on the basis of Product, Application, And Geography.

Advanced Drug Delivery Market, By Product

Polymeric Drug Delivery
Implants & IUD's
Sustained Release
Targeted Drug Delivery
Prodrugs

Based on Product, The market is segmented into Polymeric Drug Delivery, Implants & IUD's, Sustained Release, Targeted Drug Delivery, and Prodrugs. Targeted Drug Delivery has the highest growing segment of the Global Drug Delivery System Market because of increased drug accessibility, reduced toxicity, effective targeted therapy, and lowered active drug degradation over the forecasted period.

Advanced Drug Delivery Market, By Application

Hospitals
Diagnostic Centers
Ambulatory Surgical Centers/Clinics
Home Care Settings
Others

Based on the Application, The market is segmented into Hospitals, Diagnostic Centers, Ambulatory Surgical Centers/Clinics, Home Care Settings, and Others. Hospitals have the fastest-growing segment of the Global Drug Delivery System Market. because of a rise in the number of in-patients and out-patient visits, However, this leading to an increase in chronic illnesses including such neurology, cardiology, and orthopedics, as well as a growth of the market for drug delivery treatment, the highly specialized clinics segment accounting for almost half of the global Advanced Drug Delivery Market.

Advanced Drug Delivery Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Geography, The Global Advanced Drug Delivery Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is projected to be the largest growing market throughout the forecasted period. This is attributed to the increase in the integration of advanced as a result of improved drug delivery solutions, and increasing healthcare expenses in the region over the projected period.

Key Players

The "Global Advanced Drug Delivery Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
GlaxoSmithKline, Merck & Co, Antares Pharma, Allergan, F. Hoffmann-La Roche, Novartis, Sanofi, 3M, Johnson & Johnson, Pfizer, Abbott Laboratories, Bayer.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

In February 2019, Sandoz, a Novartis division and world leader in biosimilars, received European Commission authorization in Spain for its adalimumab biosimilar, HYRIMOZ, for subcutaneous injection in a syringe or a prefilled pen.

1 INTRODUCTION OF GLOBAL ADVANCED DRUG DELIVERY MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL ADVANCED DRUG DELIVERY MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL ADVANCED DRUG DELIVERY MARKET, BY PRODUCT

5.1 Overview
5.2 Implants & IUD's
5.3 Sustained Release
5.4 Targeted Drug Delivery
5.5 Prodrugs
5.6 Polymeric Drug Delivery

6 GLOBAL ADVANCED DRUG DELIVERY MARKET, BY APPLICATION

6.1 Overview
6.2 Diagnostic Centres
6.3 Ambulatory Surgical Centers/Clinics
6.4 Home Care Settings
6.5 Hospitals
6.6 Others

7 GLOBAL ADVANCED DRUG DELIVERY MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.3 Canada
- 7.2.4 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East and Africa

8 GLOBAL ADVANCED DRUG DELIVERY MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 GlaxoSmithKline
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Merck & Co
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Antares Pharma
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 Allergan
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 F. Hoffmann-La Roche
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 Novartis
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 Sanofi
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 3M
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 Johnson & Johnson
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 Pfizer
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments